113 related articles for article (PubMed ID: 22382328)
1. Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.
Kawano Y; Nagata M; Kohno T; Ichimiya A; Iwakiri T; Okumura M; Arimori K
Biol Pharm Bull; 2012; 35(3):400-7. PubMed ID: 22382328
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
3. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
5. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
Oda Y; Hidaka M; Suzuki A
Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
7. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
8. Oleuropein potentiates anti-tumor activity of cisplatin against HepG2 through affecting proNGF/NGF balance.
Sherif IO; Al-Gayyar MMH
Life Sci; 2018 Apr; 198():87-93. PubMed ID: 29476769
[TBL] [Abstract][Full Text] [Related]
9. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
Liu Z; Peng Q; Li Y; Gao Y
BMB Rep; 2018 Sep; 51(9):474-479. PubMed ID: 30103844
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.
Araújo RF; Soares LA; da Costa Porto CR; de Aquino RG; Guedes HG; Petrovick PR; de Souza TP; Araújo AA; Guerra GC
World J Gastroenterol; 2012 Aug; 18(31):4162-6168. PubMed ID: 22919249
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
13. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
15. Conflicting effects of caffeine on apoptosis and clonogenic survival of human K1 thyroid carcinoma cell lines with different p53 status after exposure to cisplatin or UVc irradiation.
Deplanque G; Céraline J; Lapouge G; Dufour P; Bergerat JP; Klein-Soyer C
Biochem Biophys Res Commun; 2004 Feb; 314(4):1100-6. PubMed ID: 14751246
[TBL] [Abstract][Full Text] [Related]
16. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.
Liu FY; Wu YH; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Huang ZY
Oncol Rep; 2014 Aug; 32(2):835-44. PubMed ID: 24919588
[TBL] [Abstract][Full Text] [Related]
17. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1.
Tan Y; Li Y
Biochem Biophys Res Commun; 2015 Oct; 466(3):592-8. PubMed ID: 26392314
[TBL] [Abstract][Full Text] [Related]
18. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma.
Li JN; Yu Y; Zhang YF; Li ZM; Cai GZ; Gong JY
Biochem Biophys Res Commun; 2017 Apr; 485(2):335-341. PubMed ID: 28219642
[TBL] [Abstract][Full Text] [Related]
19. Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma.
Qiao G; Xu H; Li C; Li X; Farooqi AA; Zhao Y; Liu X; Liu M; Stagos D; Lin X
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301274
[TBL] [Abstract][Full Text] [Related]
20. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
